NEW ORLEANS — One in two stroke survivors have poorly controlled hypertension and equally poor rates of antihypertensive therapy, according to data presented at the American Stroke Association’s International Stroke Conference.
Xuchang Hengsheng Pharmaceutical Co., Ltd.
Manidipine Hydrochloride main manufacturer in the world
NEW ORLEANS — One in two stroke survivors have poorly controlled hypertension and equally poor rates of antihypertensive therapy, according to data presented at the American Stroke Association’s International Stroke Conference.